期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
维生素B族复合TRP肽和SOD对焦虑性抑郁症C57BL/6小鼠行为学改善的影响 被引量:4
1
作者 朱西平 李文治 +2 位作者 陶倩 何文江 崔春 《食品与机械》 北大核心 2020年第3期166-172,共7页
研究了维生素B族复合TRP肽和SOD对焦虑性抑郁症C57BL/6小鼠行为学、血清炎症因子水平的改善作用以及对脑部组织抗氧化活性的影响。维生素B族复合TRP肽和SOD(V_(B3)V_(B6)TRP肽SOD=21034;VBPS)高、中、低灌胃剂量分别为260,1... 研究了维生素B族复合TRP肽和SOD对焦虑性抑郁症C57BL/6小鼠行为学、血清炎症因子水平的改善作用以及对脑部组织抗氧化活性的影响。维生素B族复合TRP肽和SOD(V_(B3)V_(B6)TRP肽SOD=21034;VBPS)高、中、低灌胃剂量分别为260,195,130mg/(kg·d)。研究表明,VBPS能够逆转焦虑性抑郁症小鼠的焦虑样和抑郁样行为、改善其体重增加缓慢的症状,VBPS高剂量组效果显著。VBPS能够降低血清炎症因子(TNF-α、IL-6、IL-1β、IFN-γ)水平和降低大脑组织丙二醛(Malondialdehyde,MDA)的含量和SOD、CAT、NOS抗氧化酶的活性。此外,VBPS可诱导色氨酸—犬尿氨酸(TRP-KYN)代谢下调和犬尿氨酸—烟酰胺腺嘌呤二核苷酸(KYN-NAD^+)代谢上调。综上所述,与焦虑性抑郁症对照组小鼠相比,VBPS治疗的小鼠具有抗炎、抗氧化、逆转焦虑性抑郁症小鼠行为障碍和体重增加缓慢的作用,从而证明膳食补充VBPS具有显著的改善焦虑性抑郁症的作用。 展开更多
关键词 维生素B族 焦虑性抑郁症 氧化应激 炎症因子 trp代谢
下载PDF
Protective effects of Zuogui Jiangtang Jieyu Formula on hippocampal neurons in rats of diabetes complicated with depression via the TRP/KYN metabolic pathway 被引量:5
2
作者 LING Jia LIU Jian +3 位作者 JIN Shi ZOU Manshu JIANG Yajie WANG Yuhong 《Digital Chinese Medicine》 2022年第2期210-221,共12页
Objective To explore the protective effects and mechanism of Zuogui Jiangtang Jieyu Formula(左归降糖解郁方,ZGJTJYF)on hippocampal neurons in rats of diabetes complicated with depression(DD)via the TRP/KYN metabolic pa... Objective To explore the protective effects and mechanism of Zuogui Jiangtang Jieyu Formula(左归降糖解郁方,ZGJTJYF)on hippocampal neurons in rats of diabetes complicated with depression(DD)via the TRP/KYN metabolic pathway.Methods(i)In vivo experiments:60 specified pathogen free(SPF)grade male Sprague-Dawley(SD)rats were randomly divided into six groups with 10 rats in each groups:control,DD model,positive(1.8 mg/kg fluoxetine+0.18 g/kg metformin),high-dose ZGJTJYF(ZGJTJYFH,40.500 g/kg ZGJTJYF),middle-dose ZGJTJYF(ZGJTJYF-M,20.250 g/kg ZGJTJYF),and lowdose ZGJTJYF(ZGJTJYF-L,10.125 g/kg ZGJTJYF)groups.Except for the control group,other groups were established DD model by high-fat emulsion intake with single tail vein streptozotocin(STZ)and four weeks of chronic unpredictable mild stress(CUMS).All drug administration groups were treated by gavage during CUMS modeling,and the control and model groups were given equal amount of distilled water.After four weeks,the serum levels of blood glucose and glycosylated hemoglobin were measured to determine the hypoglycemic effect of ZGJTJYF.Moreover,the open field test and Morris water maze test were performed to evaluate the antidepressant effect of ZGJTJYF.Changes in 5-hydroxytryptamine(5-HT)level were detected via high-performance liquid chromatography with electrochemical detection(HPLC-ECD);the levels of tryptophan(TRP),kynurenine(KYN),and indoleamine 2,3-dioxygenase(IDO)in the hippocampus were detected using enzyme-linked immunosorbent assay(ELISA);the protein expression levels of synaptophysin(SYN)and postsynaptic density material-95(PSD-95)were detected via immunohistochemistry(IHC);and the protein expression levels of N-methyl-D-aspartate receptor(NR)2 A and NR2 B were detected using Western blot.(ii)In vitro experiments:five SPF grade SD pregnant rats(E16–18)were used to obtain primary hippocampal neurons(Ne),six SD new-born rats were used to collected primary astrocytes(As)and microglia(MG),and to establish a Ne-As-MG co-culture system.All co-culture systems were divided into six groups:control(PBS),model[150 mmol/L glucose+200μmol/L corticosterone(G&P)+PBS],blank(G&P+blank serum),positive(G&P+positive drug-containing serum),ZGJTJYF(G&P+ZGJTJYF serum),and 1-methyl-D-tryptophan(1-MT,IDO inhibitor)(G&P+1-MT)groups.After 18 h of intervention by corresponding treatment,immunofluorescence was used to analyze the protein expression levels of SYN,PSD-95,NR2 A,and NR2 B;ELISA was performed to measure the levels of interleukin(IL)-1β,IL-6,tumor necrosis factor(TNF)-α,and TRP/KYN metabolic pathway-related factors[TRP,KYN,kynurenine acid(KYNA),quinolinic acid(QUIN)].Results(i)In vivo experimental results showed that ZGJTJYF-M and ZGJTJYF-L significantly improved the elevated blood glucose state of DD rats(P<0.01 and P<0.05,respectively);ZGJTJYF-H,ZGJTJYF-M,and ZGJTJYF-L increased their autonomous activity,learning,and memory ability(P<0.01,P<0.01,and P<0.05,respectively).Moreover,the levels of 5-HT and TRP were significantly increased(P<0.01),and the levels of KYN and IDO were significantly decreased in the hippocampus(P<0.01)of rats after ZGJTJYF-M treatment.The protein expression levels of SYN and PSD-95 were significantly upregulated in hippocampal neurons(P<0.01),while the abnormal activation of NR2A and NR2B was markedly inhibited in hippocampus(P<0.05)of rats after ZGJTJYF-M treatment.(ii)In vitro experimental results showed that ZGJTJYF-containing serum significantly increased the protein expression levels of SYN and PSD-95 in hippocampal neurons(P<0.01),decreased the levels of IL-1β(P<0.01),IL-6(P<0.05),TNF-α(P<0.01),IDO(P<0.05),KYN(P<0.05),and QUIN(P<0.01),and increased the levels of TRP and KYNA(P<0.01)in the simulated DD state.ZGJTJYF also had an significantly inhibitory effect on the abnormal activation of NR2A and NR2B in neurons(P<0.05)in a stimulated DD state.Conclusion ZGJTJYF can effectively improve 5-HT deficiency in the hippocampus of rats by inhibiting IDO expression and regulating the TRP/KYN metabolic pathway,and it has a favorable protective effect on hippocampal neuron injury caused by DD.Therefore,ZGJTJYF is an effective potential therapeutic drug for the prevention and treatment of DD. 展开更多
关键词 Zuogui Jiangtang Jieyu Formula(左归降糖解郁方 ZGJTJYF) DIABETES DEPRESSION Diabetes complicated with depression trp/KYN metabolic pathway Hippocampal neurons Neuroprotection 5-Hydroxytryptamine(5-HT)
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部